Webcast to be held on Monday, June 5, 2023 at 8:00 a.m. ET WALTHAM, Mass….
Webcast to be held on Monday, June 5, 2023 at 8:00 a.m. ET WALTHAM, Mass….
NewAmsterdam to review data on webcast conference call on June 5, 2023 at 8:00 a.m….
NewAmsterdam to review data on webcast conference call on June 5, 2023 at 8:00 a.m….
SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing…
SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing…
The best-in-class BrightInsight Platform accelerates the time to market for patient apps that enable biopharma…
The best-in-class BrightInsight Platform accelerates the time to market for patient apps that enable biopharma…
-Appointment expected to aid advancement of Theriva’s discovery program and strengthen collaboration with the Institut…
-Appointment expected to aid advancement of Theriva’s discovery program and strengthen collaboration with the Institut…
REDWOOD CITY, Calif., May 23, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
REDWOOD CITY, Calif., May 23, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
GeneType featured on the Balancing Act Balance Act Set with Dr. Carolynn Young and Dr….
GeneType featured on the Balancing Act Balance Act Set with Dr. Carolynn Young and Dr….
First FGF21 analog to enter Phase 3 development SAN FRANCISCO, May 23, 2023 (GLOBE NEWSWIRE)…
First FGF21 analog to enter Phase 3 development SAN FRANCISCO, May 23, 2023 (GLOBE NEWSWIRE)…
Combined company will operate under the name “TuHURA Biosciences, Inc.” and advance a personalized cancer…
Combined company will operate under the name “TuHURA Biosciences, Inc.” and advance a personalized cancer…
The Company Has Received a Portion of the Final Milestone Payment, With a Value of…
The Company Has Received a Portion of the Final Milestone Payment, With a Value of…